NuVasive EVP Sells $26,000 in Stock (NUVA)
NuVasive (NASDAQ:NUVA) EVP Jason Hannon unloaded 1,000 shares of NuVasive stock in a transaction dated Friday, October 11th. The shares were sold at an average price of $26.00, for a total transaction of $26,000.00. Following the completion of the sale, the executive vice president now directly owns 19,991 shares of the company’s stock, valued at approximately $519,766. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Several analysts have recently commented on the stock. Analysts at Goldman Sachs Group Inc. downgraded shares of NuVasive from a “neutral” rating to a “sell” rating in a research note to investors on Monday. They now have a $22.00 price target on the stock, down previously from $25.00. Separately, analysts at BMO Capital Markets upgraded shares of NuVasive from an “underperform” rating to a “market perform” rating in a research note to investors on Monday. They now have a $25.00 price target on the stock, up previously from $22.00. Finally, analysts at Needham & Company initiated coverage on shares of NuVasive in a research note to investors on Thursday, August 8th. They set a “buy” rating and a $28.00 price target on the stock. One analyst has rated the stock with a sell rating, ten have given a hold rating and eight have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $25.60.
Shares of NuVasive (NASDAQ:NUVA) traded down 2.09% during mid-day trading on Tuesday, hitting $25.28. 238,101 shares of the company’s stock traded hands. NuVasive has a 52-week low of $12.35 and a 52-week high of $27.20. The stock’s 50-day moving average is $24.31 and its 200-day moving average is $23.35. The company’s market cap is $1.126 billion.
NuVasive (NASDAQ:NUVA) last issued its quarterly earnings data on Tuesday, July 30th. The company reported $0.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by $0.03. The company had revenue of $165.70 million for the quarter, compared to the consensus estimate of $161.67 million. During the same quarter in the previous year, the company posted $0.27 earnings per share. The company’s revenue for the quarter was up 7.3% on a year-over-year basis. On average, analysts predict that NuVasive will post $1.01 earnings per share for the current fiscal year.
NuVasive, Inc (NASDAQ:NUVA) is a medical device company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.